Items tagged with Drug-resistant TB
Delamanid clinical access programme expected in South Africa (post)
The South African National Department of Health is expected to roll out a clinical access programme to allow drug-resistant tuberculosis (DR-TB) patients access to the new drug delamanid.
India: Drug-resistant TB and a promising drug (post)
World TB Day commemoration events for 2016 have just concluded. The Ministry of Health and Family Welfare announced that bedaquiline, the first new TB drug in over 40 years, will be now available in India. It had been given accelerated approval by the U.S. Food and Drug Administration in December 2012. Announcing its availability, the Ministry indicated it would be available only at six sites; in the first lot, only 600 doses will come.
ECDC report: Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA (post)
Summary
The role of moxifloxacin in tuberculosis therapy (post)
Abstract
“When treatment is more challenging than the disease”: a qualitative study of MDR-TB patient retention (post)
Abstract
TB case fatality and other causes of death among MDR-TB patients in a high HIV prevalence setting, 2000-2008, South Africa (post)
Abstract
Association between directly observed therapy and treatment outcomes in MDR-TB: a systematic review and meta-analysis (post)
Abstract
New TB drug resistance genes identified as researchers scour mycobacteria genomes (post)
NEW YORK, April 11, 2016 – By analyzing nearly 500 Mycobacterium tuberculosis genomes and performing functional studies, researchers from the Broad Institute and South Africa's KwaZulu Natal Research Institute for TB and HIV have identified a new mechanism by which the pathogen acquires drug resistance.
New Zealand’s PHARMAC to fund Sensipar; consult on Sirturo, Sylvant (post)
New Zealand’s Pharmaceutical Management Agency PHARMAC announced today (April 12) its decision to list cinacalcet (Sensipar) on the Pharmaceutical Schedule through an agreement with the local subsidiary of US biotech major Amgen (Nasdaq: ANGN) from May 1,2016 for:
Page 28 of 117 · Total posts: 0
←First 27 28 29 Last→